IN a short-term study we had shown that a significant fall in the average daily blood sugar level on the second day of treatment is a valuable criterion of future response of the diabetic patient to chlorpropamide and that a maximum fall occurs by the eighth-tenth day of treatment .
On the basis of a longer period of surveillance it was decided to investigate any relationship the blood sugar taken at an early stage of treatment might bear to the final assessment after three months' review. In routine practice it was hoped that one single blood sugar estimation done on a certain day of treatment might be sufficiently reliable in predicting the outcome of chlorpropamide treatment.
MATERIALS AND METHODS. Forty diabetic patients diagnosed after the age of 40 years were studied. Estimations of true blood glucose were perforined on venous blood by a modification of the anthrone method of Handelsman and Sass (1956 After an initial five days on diet alone (control period), during which blood sugars were taken as stated, the patients were started on chlorpropamide 500 mgs. as a single morning dose. Following the first five days of treatment blood samples were again drawn inclusive of the sixth-tenth days of treatment; designated the treatment period. The mean values for all the blood sugars during the two periods observed were calculated for each patient (control period B.S.L. inean and treatmient period B.S.L. mean). These levels were ulsed for statistical analysis by scatter diagram, any correlation being compared with the patient's response category after three months' treatment.
The criteria of response to chlorpropamide treatment used were modified from those of Cardonnet, et al. (1959) , and Sugar, et al. (1949) , being the same response categories previously set out Hadley, et al. (1959) , occasionally have both shown results discrepant with the observed outcome of chlorpropamide treatment. We have been unable to find any correlation between the profile or blood sugar levels of the initial glucose tolerance test and the subsequent response category in chlorpropamide-treated diabetics . It has indeed been suggested that the only reliable guide to assessing chlorpropamide response in any diabetic patient is by clinical trial.
In the present study the conclusion previously reached that high initial fasting and average daily blood sugar levels do not preclude good clinical control with chlorpropamide is further confirmed, following three months' survelliance of a larger series of patients. That a progressive fall in average daily blood sugar occurs over a period of five-eight days treatment ) is similarly verified. Although Lee, et al. (1959) , state that the maximum response to chlorpropamide may be delayed until four weeks or longer, no patient in this series who failed at ten days showed a later response to therapy.
On comparison of Figs. 1 and 2 the similarity of scatter is very evident, suggesting that the fasting blood sugar level on the tenth day of treatment can be taken as representing the established effect of 500 mgs. of chlorpropamide, a dosage level accepted as adequate (Hamwi, et al. (1959) , Knick, et al. (1959) , and others). Indeed, Cardonnet, et al. (1959) , suggests that a dosage of 750 mgs. daily should not be exceeded. The conclusion is reached, therefore, that all patients with excellent or good eventual responses will be expected to have a fasting blood sugar on the tenth day of treatment, below 165 mg./100 ml.
Analysis of the patients who showed an inferior response to chlorpropamide presents many problems. The answer to these gets close to solving the problem of the fundamental action of sulphonyl urea drugs in the dialbetic patient.
The two patients in the fair category had fasting blood sugars on the tenth day of treatment of just over 180 mg./100 ml. and 310 mg./10: ml. respectively, while that of the poor response patient was 190 mg./100 ml. (Fig. 2) . In Fig. 1 the treatment period B.S.L. mean showed a comparable picture in regard to the "fair" and "poor" responses. Of the two "fair" cases, the lower of the two, whose reading fell just above the excellent category response limit, was eating outside her diet, and on strict diet very probably would have fallen into the excellent or good response group. The other "fair" response patient was 170 per cent. of ideal weight, while the patient with a "poor" response was overweight by 54 per cent. This is in agreement with the previous observation that obese patients tend to have an inferior response to chlorpropamide, requiring higher dosage than those approaching their norm in weight (Grant and Boyd, 1959 
